BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29017049)

  • 41. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
    Radzisheuskaya A; Shliaha PV; Grinev V; Lorenzini E; Kovalchuk S; Shlyueva D; Gorshkov V; Hendrickson RC; Jensen ON; Helin K
    Nat Struct Mol Biol; 2019 Nov; 26(11):999-1012. PubMed ID: 31611688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.
    Jensen-Pergakes K; Tatlock J; Maegley KA; McAlpine IJ; McTigue M; Xie T; Dillon CP; Wang Y; Yamazaki S; Spiegel N; Shi M; Nemeth A; Miller N; Hendrickson E; Lam H; Sherrill J; Chung CY; McMillan EA; Bryant SK; Palde P; Braganza J; Brooun A; Deng YL; Goshtasbi V; Kephart SE; Kumpf RA; Liu W; Patman RL; Rui E; Scales S; Tran-Dube M; Wang F; Wythes M; Paul TA
    Mol Cancer Ther; 2022 Jan; 21(1):3-15. PubMed ID: 34737197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.
    Zhang HT; Zhang D; Zha ZG; Hu CD
    Biochim Biophys Acta; 2014 Nov; 1839(11):1330-40. PubMed ID: 25281873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.
    Gerhart SV; Kellner WA; Thompson C; Pappalardi MB; Zhang XP; Montes de Oca R; Penebre E; Duncan K; Boriack-Sjodin A; Le B; Majer C; McCabe MT; Carpenter C; Johnson N; Kruger RG; Barbash O
    Sci Rep; 2018 Jun; 8(1):9711. PubMed ID: 29946150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PRMT5: a putative oncogene and therapeutic target in prostate cancer.
    Beketova E; Owens JL; Asberry AM; Hu CD
    Cancer Gene Ther; 2022 Mar; 29(3-4):264-276. PubMed ID: 33854218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 47. Localization and stability of introns spliced from the Pem homeobox gene.
    Clement JQ; Maiti S; Wilkinson MF
    J Biol Chem; 2001 May; 276(20):16919-30. PubMed ID: 11278282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell metabolic profiling of colorectal cancer via
    Ge S; Zhang Q; Tian Y; Hao L; Duan J; Zhang B
    Clin Chim Acta; 2020 Nov; 510():291-297. PubMed ID: 32707041
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer.
    Kanda M; Shimizu D; Fujii T; Tanaka H; Shibata M; Iwata N; Hayashi M; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2016 Sep; 49(3):1195-202. PubMed ID: 27315569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proliferative role of TRAF4 in breast cancer by upregulating PRMT5 nuclear expression.
    Yang F; Wang J; Ren HY; Jin J; Wang AL; Sun LL; Diao KX; Wang EH; Mi XY
    Tumour Biol; 2015 Aug; 36(8):5901-11. PubMed ID: 25704480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.
    Sakai N; Saito Y; Fujiwara Y; Shiraki T; Imanishi Y; Koshimizu TA; Shibata K
    Biochem Biophys Res Commun; 2015 Nov; 467(4):778-84. PubMed ID: 26482848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PRMT5 and CDK4/6 inhibition result in distinctive patterns of alternative splicing in melanoma.
    Chan LH; Wang P; Abuhammad S; Lim LRJ; Cursons J; Sheppard KE; Goode DL
    PLoS One; 2023; 18(11):e0292278. PubMed ID: 37917641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
    Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma.
    Yang D; Liang T; Gu Y; Zhao Y; Shi Y; Zuo X; Cao Q; Yang Y; Kan Q
    Oncol Rep; 2016 Mar; 35(3):1703-10. PubMed ID: 26708443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions.
    Chakrapani B; Khan MIK; Kadumuri RV; Gupta S; Verma M; Awasthi S; Govindaraju G; Mahesh A; Rajavelu A; Chavali S; Dhayalan A
    Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
    Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
    Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PRMT5 regulates colorectal cancer cell growth and EMT via EGFR/Akt/GSK3β signaling cascades.
    Yan Y; Zhao P; Wang Z; Liu Z; Wang Z; Zhang J; Ding Y; Hua X; Yu L
    Aging (Albany NY); 2021 Jan; 13(3):4468-4481. PubMed ID: 33495409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
    Jing P; Zhao N; Ye M; Zhang Y; Zhang Z; Sun J; Wang Z; Zhang J; Gu Z
    Cancer Lett; 2018 Jul; 427():38-48. PubMed ID: 29679612
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
    Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
    Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cotranscriptional recruitment of yeast TRAMP complex to intronic sequences promotes optimal pre-mRNA splicing.
    Kong KY; Tang HM; Pan K; Huang Z; Lee TH; Hinnebusch AG; Jin DY; Wong CM
    Nucleic Acids Res; 2014 Jan; 42(1):643-60. PubMed ID: 24097436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.